Products
Barbexaclone dragées (maliasin, Abbott AG) are no longer available (over-the-counter) in many countries as of May 2010. Abbott AG discontinued production worldwide in 2009.
Structure and properties
Barbexaclone is a compound of phenobarbital and L-propylhexedrine:
Effects
See under phenobarbital and barbiturates. L-propylhexedrine is a central stimulant and antagonizes the clinically undesirable sedation of seizure patients caused by phenobarbital.
Indications
Epilepsy
